oral semaglutide tablets ACC 2025: Reduces Cardiovascular Events by 14% at 4 Years contain semaglutide Oral Semaglutide Gets FDA Approval

Vitamin D to regulate immune activity

(2024) found that CS extract 2-deoxyadenosine mitigated AKI by improving renal pathophysiological alterations and inhibiting the expression of perforin and IFN- released from NK cells through the STING/IRF3 signaling pathway, thereby reducing damage to RTECs

Thymoquinone-enriched naringenin-loaded nanostructured lipid carrier for brain delivery via nasal route: in vitro prospect and in vivo therapeutic efficacy for the treatment of depression

A significant decrease in arachidonate levels (20:4n-6) may be the cause of anti-inflammatory effects

Reduced redness after sun exposure 2